Status:
RECRUITING
Acceptability and Feasibility of a Brief Paranoia Intervention.
Lead Sponsor:
Lucy Jonas
Conditions:
Paranoia
Eligibility:
All Genders
16-18 years
Phase:
NA
Brief Summary
The goal of this feasibility and acceptability trial is to test whether a new brief talking therapy can be successfully provided to and is suitable for adolescents (16-18) who are seeking help from Ch...
Detailed Description
Paranoia involves intense fears that others intend to cause harm. This fear of being under threat and unable to trust others often causes a young person significant distress and impairs everyday funct...
Eligibility Criteria
Inclusion Criteria:
- Aged 16-18
- Seeking help from a Child and Adolescent Mental Health Service (CAMHS)
- A score ≥ 11 on the R-GPTS (Scale B)
- Sufficient understanding of English
- Capacity to consent, as assessed during the initial interview
- Wanting support with paranoia
- Low- moderate mental health risks (emotional difficulties that impact functioning, but no immediate risk to safety e.g., no suicidal intent).
Exclusion Criteria:
- Severe comorbid diagnoses apparent at the initial assessment (e.g., a primary alcohol or substance dependence issue measured using standardised assessments)
- The presence of a developmental disability or cognitive impairment that would interfere with participation.
- Concurrent participation in another psychological therapy
- High levels of current risk (e.g., significant and immediate concerns about the young person's safety, such as suicidal intent).
Key Trial Info
Start Date :
October 24 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2026
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT07350954
Start Date
October 24 2025
End Date
May 1 2026
Last Update
January 20 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Westminster's Child and Adolescent Mental Health Service
London, United Kingdom, W9 2NW